What We're Reading: Page 253
Industry reads hand-picked by our editors
Jun 14, 2018
Jun 13, 2018
-
Bloomberg
The Quant King, the Drug Hunter, and the Quest to Unlock New Cures
-
The Wall Street Journal
Ever Heard of Iqvia? Its CEO Made $38 Million
-
Wired
How Pharma Hides Data About Farm Antibiotic Use
Jun 12, 2018
-
Bloomberg
Drugmaker Revives Female Libido Pill at Half the Price
-
The Wall Street Journal
Stryker Offer May Trigger Billions in Deal Making
-
Financial Times
Kyoto strides ahead in regenerative medicine race
Jun 11, 2018
Jun 08, 2018
-
CNBC
Geisinger CEO David Feinberg is not going to lead the Amazon-Berkshire-JPMorgan health venture
-
The Wall Street Journal
Buffett, Dimon team up to curb ‘unhealthy focus’ on quarterly earnings
-
The Economist
Artificial intelligence will improve medical treatments
-
Forbes
Bill and Melinda Gates start a nonprofit biotech in Boston
Jun 07, 2018
-
Forbes
A biotech executive faces end-stage cancer as a patient
-
The New York Times
A promising cancer treatment made patients worse, not better
-
Bloomberg
Zero profit, 750% return: Biotech’s sick ride
-
Medical Marketing & Media
Is it time for pharma ad agencies to reboot?
Previous
